SPRINT issues final report finding fewer cardiovascular events with intensive blood pressure control
Patients treated to a systolic blood pressure target less than 120 mm Hg instead of less than 140 mm Hg had lower rates of cardiovascular events but more incidence of some adverse events, according to new follow-up data.
25 May 2021
Missing an adult diagnosis of attention deficit hyperactivity disorder (ADHD) means patients also miss out on effective, often life-changing treatment.
1 Apr 2023
A Danish study also found that more men with ischemic heart disease are taking both nitrates and a phosphodiesterase type 5 (PDE5) inhibitor, with the prescription rate increasing 20-fold from 2000 to 2018.
19 Apr 2022
Compared to other NSAIDs, celecoxib and meloxicam were associated with a lower risk of bleeding or cardiovascular events among Korean patients who had a myocardial infarction (MI).
28 Jul 2020
Home measurement of high blood pressure overcomes variability inherent in office measurements, delivers better assessment of systolic pressure (and hence, of possible cardiovascular events) and offers a better chance of discontinuing drug therapy.
1 Mar 2011
A retrospective study found that gout patients who experienced an acute myocardial infarction or stroke had significantly higher odds of a recent gout flare in the preceding four months than those who did not.
9 Aug 2022
This column reviews recent recalls, alerts, and approvals.
1 Jun 2023
A retrospective cohort study in Canada found that the relative risk for major cardiovascular events with or without heart failure increased in adults ages 18 to 39 years with an eGFR below 80 mL/min/1.73 m2.
19 Sep 2023
Cardiovascular events similar, adverse effects worse with chlorthalidone compared to hydrochlorothiazide
Chlorthalidone was associated with a significantly higher risk of hypokalemia, hyponatremia, acute renal failure, chronic kidney disease, type 2 diabetes, and abnormal weight gain.
25 Feb 2020
Choosing among glucagon-like peptide-1 (GLP-1) receptor agonists depends on many factors, such as the desired outcome and individual risks among patients.
1 Mar 2023